Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Tron

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Archives of Cardiovascular Diseases|April 24, 2012
Transapical aortic valve implantation in Rouen: four years' experience with the Edwards transcatheter prosthesisPierre-Yves Litzler, Bogdan Borz, Hassiba Smail, et al.
The American Journal of Cardiology|October 31, 2013
Comparison of two antiplatelet therapy strategies in patients undergoing transcatheter aortic valve implantationEric Durand, Didier Blanchard, Stephan Chassaing, et al.
Circulation. Cardiovascular Interventions|April 19, 2019
Assessment of Long-Term Structural Deterioration of Transcatheter Aortic Bioprosthetic Valves Using the New European DefinitionEric Durand, Anastasia Sokoloff, Marina Urena-Alcazar, et al.
The American Journal of Cardiology|March 4, 2019
Usefulness of Clopidogrel Loading in Patients Who Underwent Transcatheter Aortic Valve Implantation (from the BRAVO-3 Randomized Trial)Vincent Johan Nijenhuis, Jurrien Maria Ten Berg, Christian Hengstenberg, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 28, 2021
Impact of anemia on short-term outcomes after TAVR: A subgroup analysis from the BRAVO-3 randomized trialVictor Razuk, Anton Camaj, Davide Cao, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 10, 2023
Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO-3 randomized trialDaniel Feldman, Davide Cao, Samantha Sartori, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 7, 2019
Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO-3 randomized trialRobert Zilberszac, Rishi Chandiramani, Christian Hengstenberg, et al.
International Journal of Cardiology|October 22, 2019
Impact of diabetes mellitus on short term vascular complications after TAVR: Results from the BRAVO-3 randomized trialRidhima Goel, David Power, Didier Tchetche, et al.
ESC Heart Failure|May 23, 2025
Acute myocarditis according to age: Presentation, management and early outcomesClément Karsenty, Paul Vignaud, Clara Brusq, et al.
Archives of Cardiovascular Diseases|June 4, 2024
Phenotypic clustering of patients hospitalized in intensive cardiac care units: Insights from the ADDICT-ICCU studyKenza Hamzi, Emmanuel Gall, François Roubille, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Archives of Cardiovascular Diseases|April 24, 2012
Transapical aortic valve implantation in Rouen: four years' experience with the Edwards transcatheter prosthesisPierre-Yves Litzler, Bogdan Borz, Hassiba Smail, et al.
The American Journal of Cardiology|October 31, 2013
Comparison of two antiplatelet therapy strategies in patients undergoing transcatheter aortic valve implantationEric Durand, Didier Blanchard, Stephan Chassaing, et al.
Circulation. Cardiovascular Interventions|April 19, 2019
Assessment of Long-Term Structural Deterioration of Transcatheter Aortic Bioprosthetic Valves Using the New European DefinitionEric Durand, Anastasia Sokoloff, Marina Urena-Alcazar, et al.
The American Journal of Cardiology|March 4, 2019
Usefulness of Clopidogrel Loading in Patients Who Underwent Transcatheter Aortic Valve Implantation (from the BRAVO-3 Randomized Trial)Vincent Johan Nijenhuis, Jurrien Maria Ten Berg, Christian Hengstenberg, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 28, 2021
Impact of anemia on short-term outcomes after TAVR: A subgroup analysis from the BRAVO-3 randomized trialVictor Razuk, Anton Camaj, Davide Cao, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 10, 2023
Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO-3 randomized trialDaniel Feldman, Davide Cao, Samantha Sartori, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 7, 2019
Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO-3 randomized trialRobert Zilberszac, Rishi Chandiramani, Christian Hengstenberg, et al.
International Journal of Cardiology|October 22, 2019
Impact of diabetes mellitus on short term vascular complications after TAVR: Results from the BRAVO-3 randomized trialRidhima Goel, David Power, Didier Tchetche, et al.
ESC Heart Failure|May 23, 2025
Acute myocarditis according to age: Presentation, management and early outcomesClément Karsenty, Paul Vignaud, Clara Brusq, et al.
Archives of Cardiovascular Diseases|June 4, 2024
Phenotypic clustering of patients hospitalized in intensive cardiac care units: Insights from the ADDICT-ICCU studyKenza Hamzi, Emmanuel Gall, François Roubille, et al.
Pageof 7